Raterman, Hennie G. http://orcid.org/0000-0001-9972-2844
Bultink, Irene E. M. http://orcid.org/0000-0002-5441-3420
Lems, Willem F.
Article History
First Online: 14 June 2019
Compliance with Ethical Standards
:
: The authors declare that there was no funding for the preparation of this article.
: Hennie G. Raterman received an unrestricted educational grant by UCB and consultant fees by Amgen, Cell gene and Sanof Genzyme. Irene E. M. Bultink received consultant and/or speaker fees (not related to the subject matter discussed in this manuscript) from Eli Lilly and Company Netherlands, Merck Sharpe and Dohme, Amgen, UCB Pharma, Roche Netherlands, and Sanofi Genzyme. W. F. Lems received consultant and/or speaker fees from Eli Lilly/Amgen/UCB Pharma, and Curaphar.